Growth in Estonia's pharma market "to continue"
This article was originally published in Scrip
Executive Summary
The Estonian pharmaceutical market may still grow by around 1.3% this year, despite declining in the first half as a result of a general economic downturn, says the Estonia Pharmaceuticals & Healthcare Report Q4 2009 from Business Monitor International. Wholesalers reported sales of EEK747 million ($67 million; -0.5%) in the second quarter; those of prescription drugs fell by 0.2% and of OTC products by 1.6%.